trending Market Intelligence /marketintelligence/en/news-insights/trending/fr3wwhag6ud6ebapr_dzlq2 content esgSubNav
In This List

Viveve to fund commercialization of products through public offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Viveve to fund commercialization of products through public offering

California based Viveve Medical Inc. priced its previously announced public offering of 10 million shares at $3 apiece.

The offering is expected to close by Feb. 12 with Cowen acting as sole book-running manager and Raymond James acting as lead manager. Ladenburg Thalmann & Co. Inc. and Maxim Group LLC are acting as co-managers for the offering.

The underwriters can purchase up to an additional 1.5 million shares of the company.

The women's health company plans to use the net proceeds to fund the commercialization of its products, clinical research and development, working capital, and general corporate purposes.